chr7-30609724-T-G

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP5_Moderate

The NM_002047.4(GARS1):​c.875T>G​(p.Met292Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 33)

Consequence

GARS1
NM_002047.4 missense

Scores

4
7
7

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 6.19
Variant links:
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-30609724-T-G is Pathogenic according to our data. Variant chr7-30609724-T-G is described in ClinVar as [Pathogenic]. Clinvar id is 476764.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GARS1NM_002047.4 linkc.875T>G p.Met292Arg missense_variant Exon 7 of 17 ENST00000389266.8 NP_002038.2 P41250-1
GARS1NM_001316772.1 linkc.713T>G p.Met238Arg missense_variant Exon 7 of 17 NP_001303701.1 P41250-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GARS1ENST00000389266.8 linkc.875T>G p.Met292Arg missense_variant Exon 7 of 17 1 NM_002047.4 ENSP00000373918.3 P41250-1
GARS1ENST00000675651.1 linkc.875T>G p.Met292Arg missense_variant Exon 7 of 17 ENSP00000502513.1 A0A6Q8PGZ8
GARS1ENST00000675810.1 linkc.773T>G p.Met258Arg missense_variant Exon 6 of 16 ENSP00000502743.1 A0A6Q8PHH9
GARS1ENST00000675693.1 linkc.707T>G p.Met236Arg missense_variant Exon 8 of 18 ENSP00000502174.1 A0A6Q8PGA8
GARS1ENST00000675051.1 linkc.674T>G p.Met225Arg missense_variant Exon 7 of 17 ENSP00000502296.1 A0A6Q8PGI6
GARS1ENST00000674815.1 linkc.506T>G p.Met169Arg missense_variant Exon 7 of 17 ENSP00000502799.1 A0A6Q8PGW4
GARS1ENST00000674851.1 linkc.506T>G p.Met169Arg missense_variant Exon 8 of 18 ENSP00000502451.1 A0A6Q8PGW4
GARS1ENST00000444666.6 linkn.875T>G non_coding_transcript_exon_variant Exon 7 of 18 3 ENSP00000415447.2 H7C443
GARS1ENST00000674616.1 linkn.*589T>G non_coding_transcript_exon_variant Exon 8 of 18 ENSP00000502408.1 A0A6Q8PGT3
GARS1ENST00000674643.1 linkn.875T>G non_coding_transcript_exon_variant Exon 7 of 17 ENSP00000501636.1 A0A6Q8PF45
GARS1ENST00000674737.1 linkn.*213T>G non_coding_transcript_exon_variant Exon 8 of 18 ENSP00000502464.1 A0A6Q8PGZ9
GARS1ENST00000674807.1 linkn.875T>G non_coding_transcript_exon_variant Exon 7 of 16 ENSP00000502814.1 A0A6Q8PFZ6
GARS1ENST00000675529.1 linkn.*745T>G non_coding_transcript_exon_variant Exon 8 of 18 ENSP00000501655.1 A0A6Q8PFN0
GARS1ENST00000675859.1 linkn.875T>G non_coding_transcript_exon_variant Exon 7 of 15 ENSP00000502033.1 A0A6Q8PFZ6
GARS1ENST00000676088.1 linkn.*817T>G non_coding_transcript_exon_variant Exon 9 of 19 ENSP00000501884.1 A0A6Q8PFN0
GARS1ENST00000676140.1 linkn.875T>G non_coding_transcript_exon_variant Exon 7 of 17 ENSP00000502571.1 A0A6Q8PH49
GARS1ENST00000676164.1 linkn.*326T>G non_coding_transcript_exon_variant Exon 7 of 17 ENSP00000501986.1 A0A6Q8PFV5
GARS1ENST00000676210.1 linkn.*164T>G non_coding_transcript_exon_variant Exon 8 of 18 ENSP00000502373.1 A0A6Q8PGN7
GARS1ENST00000676259.1 linkn.*307T>G non_coding_transcript_exon_variant Exon 7 of 17 ENSP00000501980.1 A0A6Q8PFU7
GARS1ENST00000676403.1 linkn.875T>G non_coding_transcript_exon_variant Exon 7 of 16 ENSP00000502681.1 A0A6Q8PHI7
GARS1ENST00000674616.1 linkn.*589T>G 3_prime_UTR_variant Exon 8 of 18 ENSP00000502408.1 A0A6Q8PGT3
GARS1ENST00000674737.1 linkn.*213T>G 3_prime_UTR_variant Exon 8 of 18 ENSP00000502464.1 A0A6Q8PGZ9
GARS1ENST00000675529.1 linkn.*745T>G 3_prime_UTR_variant Exon 8 of 18 ENSP00000501655.1 A0A6Q8PFN0
GARS1ENST00000676088.1 linkn.*817T>G 3_prime_UTR_variant Exon 9 of 19 ENSP00000501884.1 A0A6Q8PFN0
GARS1ENST00000676164.1 linkn.*326T>G 3_prime_UTR_variant Exon 7 of 17 ENSP00000501986.1 A0A6Q8PFV5
GARS1ENST00000676210.1 linkn.*164T>G 3_prime_UTR_variant Exon 8 of 18 ENSP00000502373.1 A0A6Q8PGN7
GARS1ENST00000676259.1 linkn.*307T>G 3_prime_UTR_variant Exon 7 of 17 ENSP00000501980.1 A0A6Q8PFU7

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 2 Pathogenic:1
Jun 21, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

For these reasons, this variant has been classified as Pathogenic. This sequence change replaces methionine with arginine at codon 292 of the GARS protein (p.Met292Arg). The methionine residue is moderately conserved and there is a moderate physicochemical difference between methionine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been shown to arise de novo in an individual affected with Charcot-Marie-Tooth disease (CMT) type 2 (PMID: 26244500). In addition, it has been observed in 2 affected individuals (Invitae). This variant is also known as p.M238R in the literature. ClinVar contains an entry for this variant (Variation ID: 457156). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.40
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.050
CADD
Uncertain
25
DANN
Uncertain
0.97
DEOGEN2
Uncertain
0.56
D
Eigen
Benign
-0.088
Eigen_PC
Benign
0.16
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.97
D
M_CAP
Benign
0.064
D
MetaRNN
Uncertain
0.71
D
MetaSVM
Benign
-0.75
T
PrimateAI
Pathogenic
0.84
D
PROVEAN
Uncertain
-3.6
D
REVEL
Uncertain
0.44
Sift
Benign
0.10
T
Sift4G
Benign
0.087
T
Polyphen
0.050
B
Vest4
0.84
MutPred
0.45
Gain of methylation at M292 (P = 0.0449);
MVP
0.55
MPC
0.98
ClinPred
0.97
D
GERP RS
5.5
Varity_R
0.80
gMVP
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1064795123; hg19: chr7-30649340; API